Presenting symptoms and predictors of poor outcomes among 2,184 patients with COVID-19 in Lagos State, Nigeria

dc.creatorAbayomi, Akin
dc.creatorOdukoya, Oluwakemi
dc.creatorOsibogun, Akin
dc.creatorWright, Ololade
dc.creatorAdebayo, Bisola
dc.creatorBalogun, Mobolanle
dc.creatorAbdus-Salam, Ismael
dc.creatorBowale, Abimbola
dc.creatorMutiu, Bamidele
dc.creatorSaka, Babatunde
dc.creatorAdejumo, Moyosore
dc.creatorYenyi, Sam
dc.creatorAgbolagorite, Rotimi
dc.creatorOnasanya, Oluwatosin
dc.creatorErinosho, Eniola
dc.creatorObasanya, Joshua
dc.creatorAdejumo, Olu
dc.creatorAdesola, Sunday
dc.creatorOshodi, Yewande
dc.creatorAkase, Iorhen E.
dc.creatorOgunbiyi, Shina
dc.creatorLajide, Dayo
dc.creatorErinoso, Femi
dc.creatorAbdur-Razzaq, Hussein
dc.date.accessioned2020-10-21T19:43:06Z
dc.date.available2020-10-21T19:43:06Z
dc.date.created2020
dc.description.abstractIntroduction: Lagos state remains the epicentre of COVID-19 in Nigeria. We describe the symptoms and signs of the first 2,184 PCR-confirmed COVID-19 patients admitted at COVID-19 treatment centers in Lagos State. We also assessed the relationship between patients’ presenting symptoms, sociodemographic and clinical characteristics and COVID-19 deaths.. Methods: Medical records of PCR-confirmed COVID-19 patients were extracted and analyzed for their symptoms, symptom severity, presence of comorbidities and outcome. Results: The ages of the patients ranged from 4 days to 98 years with a mean of 43.0(16.0) years. Of the patients who presented with symptoms, cough (19.3%) was the most common presenting symptom. This was followed by fever (13.7%) and difficulty in breathing, (10.9%). The most significant clinical predictor of death was the severity of symptoms and signs at presentation. Difficulty in breathing was the most significant symptom predictor of COVID-19 death (OR:19.26 95% CI 10.95-33.88). The case fatality rate was 4.3%. Conclusion: Primary care physicians and COVID-19 frontline workers should maintain a high index of suspicion and prioritize the care of patients presenting with these symptoms. Community members should be educated on such predictors and ensure that patients with these symptoms seek care early to reduce the risk of deaths associated with COVID-19.spa
dc.format.extent21 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.1016/j.ijid.2020.10.024spa
dc.identifier.issn1201-9712spa
dc.identifier.otherhttps://doi.org/10.1016/j.ijid.2020.10.024spa
dc.identifier.urihttps://hdl.handle.net/20.500.12010/14667
dc.language.isoengspa
dc.publisherInternational Journal of Infectious Diseasesspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.localAbierto (Texto Completo)spa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectCOVID-19spa
dc.subjectSymptomsspa
dc.subjectDeathspa
dc.subjectNigeriaspa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.titlePresenting symptoms and predictors of poor outcomes among 2,184 patients with COVID-19 in Lagos State, Nigeriaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.localArtículospa

Archivos

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
2.87 KB
Formato:
Item-specific license agreed upon to submission
Descripción: